AEON Biopharma (AEON) Operating Expenses (2021 - 2026)
AEON Biopharma (AEON) posted Operating Expenses of $5.5 million for Q4 2025, up 121.06% sequentially from $2.5 million in Q3 2025, and up 137.44% YoY from $2.3 million in Q4 2024.
AEON Biopharma (AEON) Operating Expenses (2021 - 2026) Analysis & Trends
AEON Biopharma has reported Operating Expenses for 5 years, with the latest figure at $5.5 million in Q4 2025.
- Quarterly Operating Expenses rose 137.44% year-over-year to $5.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.8 million (up 117.54% YoY) and the FY2025 annual result came in at $12.8 million, up 117.54% from the prior year.
- Operating Expenses rose to $5.5 million in Q4 2025 per AEON's latest filing, from $2.5 million in the prior quarter.
- Over five years, Operating Expenses peaked at $283.7 million in Q3 2023 and troughed at -$153.5 million in Q2 2024.
- A 5-year average of $14.6 million and a median of $2.5 million in 2025 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 3253.1% in 2023, then plunged 1198.51% in 2024.
- Over 5 years, Operating Expenses stood at $885744.0 in 2021, then soared by 1597.22% to $15.0 million in 2022, then jumped by 1787.27% to $283.7 million in 2023, then plunged by 99.18% to $2.3 million in 2024, then surged by 137.44% to $5.5 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $5.5 million, $2.5 million, and $4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | AEON Biopharma | 10.06 Mn | 6.62 Mn | - | 5.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.92 Mn |
| Dec 31, 2025 | 5.51 Mn |
| Sep 30, 2025 | 2.49 Mn |
| Jun 30, 2025 | 4.34 Mn |
| Mar 31, 2025 | 462,000.00 |
| Dec 31, 2024 | 2.32 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Jun 30, 2024 | -153.47 Mn |
| Mar 31, 2024 | 74.15 Mn |
| Sep 30, 2023 | 283.71 Mn |
| Jun 30, 2023 | 13.97 Mn |
| Mar 31, 2023 | 13.05 Mn |
| Dec 31, 2022 | 15.03 Mn |
| Sep 30, 2022 | 9.91 Mn |
| Jun 30, 2022 | 427,204.00 |
| Mar 31, 2022 | 389,073.00 |
| Dec 31, 2021 | 885,744.00 |
| Sep 30, 2021 | 450,892.00 |
| Jun 30, 2021 | 398,443.00 |
| Mar 31, 2021 | 200,863.00 |